IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?
The role of selective I1 imidazoline receptor agonists and moxonidine in particular , in modern antihypertensive therapy is discussed. Moxonidine advantages, namely positive effects on insulin resistance, endothelial dysfunction, lipid profile, and plasma fibrinolytic activity are considered.
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Столичная издательская компания
2015-12-01
|
| coleção: | Рациональная фармакотерапия в кардиологии |
| Assuntos: | |
| Acesso em linha: | https://www.rpcardio.online/jour/article/view/564 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|